SCHEMBL7662207

SCHEMBL7662207

[CH2]c1ccc([CH2])c(CNC(=N)N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8356400 0.78 MTNR1A (0.37) —
SCHEMBL7273445 0.73 CYP2C9 (0.41) —
SCHEMBL7665342 0.68 — —
SCHEMBL9578764 0.68 PNMT (0.31) —
SCHEMBL9578895 0.68 GRIA1 (0.33) —
SCHEMBL4826085 0.65 GRIN2D (0.36) —
SCHEMBL3672272 0.65 CYP2C9 (0.48) —
SCHEMBL7442506 0.65 SLC11A2 (0.35) —
SCHEMBL5185932 0.64 GABRA1 (0.42) —
SCHEMBL10310220 0.64 MAPK8 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376534-B1 GUANIDINE COMPOUND; SIDE EFFECT REDUCTION ASTRAZENECA CANADA INC. (CA) 2002-04-23 — — US disclosed
Send feedback